News
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...
An Ozempic warning has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for any women taking ...
A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.
Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and ...
A global review reveals over 100 new dementia drugs which could halt or even reverse the disease are going through clinical ...
Regeneron Pharmaceuticals said on Monday its experimental weight-loss drug combination helped preserve muscle mass in a ...
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
Dementia experts have said that "hope is on the horizon" after a new review shows a rise in the number of potential drugs ...
12d
Stocktwits on MSNRegeneron To Buy Licensing Rights For China-Developed Investigational Obesity Drug For $2B: Retail Sees Stock Hitting $500Regeneron Pharmaceuticals, Inc. (REGN) on Monday said that it has entered into a strategic in-licensing agreement with ...
Other factors that influence the impact include how much people need to eat to full feel. Researchers say they have a new ...
Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results